Abstract：Objective: To investigate the characteristics of pulmonary function and risk factors of emphysema in elderly patients with pulmonary interstitial fibrosis complicated with emphysema syndrome (CPEF). Methods: The study included 144 eligible elderly patients with pulmonary interstitial fibrosis admitted to West China Hospital of Sichuan University from February 2019 to February 2022.Among these patients,90 were diagnosed with emphysema (CPEF group),and 54 had pulmonary interstitial fibrosis alone (control group).The study compared changes in pulmonary function parameters,blood routine,erythrocyte sedimentation rate,and other laboratory indicators between the two groups.Both univariate and multivariate methods were used to analyze the relationship between various factors and the development of pulmonary hypertension in patients with CPEF. Results: The study found no statistically significant differences in the FVC% pred and FEV1% pred measurements between the CPEF group and the control group (P>0.05).However,the FEV1/FVC and DLCO% pred measurements in the CPEF group were lower compared to the control group.Additionally,the CPEF group showed higher values for TLC% pred and RV% pred measurements compared to the control group,with these differences being statistically significant (P<0.05).The CPEF group had a higher proportion of male patients,a higher percentage of patients with a history of smoking,and a higher smoking index compared to the control group,and these differences were statistically significant (P<0.05).A logistic regression analysis revealed that male patients,smoking history,increased smoking index,decreased ALB (albumin),and decreased RDW (red blood cell distribution width) were independent risk factors for emphysema in patients with pulmonary interstitial fibrosis (P<0.05). Conclusion: Elderly patients with pulmonary interstitial fibrosis complicated by emphysema syndrome typically present with aggravated dyspnea and reduced pulmonary diffusion function.Risk factors for developing emphysema in these patients include male gender,smoking history,and decreased levels of ALB and RDW.
周璇, 谢莉, 邹娟, 寇咏. 老年肺间质纤维化合并肺气肿综合征患者肺功能特征及其危险因素研究[J]. 河北医学, 2023, 29(11): 1872-1876.
ZHOU Xuan, XIE Li, ZOU Juan, et al. A Study of Pulmonary Function Characteristics and Risk Factors in Elderly Patients with Combined Pulmonary Fibrosis and Emphysema. HeBei Med, 2023, 29(11): 1872-1876.
[1] 曾绮娴,罗勤,赵青,等.肺纤维化合并肺气肿综合征并发肺动脉高压患者的临床特征分析[J].中国循环杂志,2020,35(10):1000-1005. [2] 吴苏佶,魏毅,石俊青,等.肺纤维化合并肺气肿综合征的临床特征与危险因素分析[J].中国呼吸与危重监护杂志,2021,20(1):4-11. [3] 石涵宇,董彦,魏路清,等.肺纤维化合并肺气肿综合征并发肺动脉高压的Meta分析[J].中华肺部疾病杂志(电子版),2019,12(3):289-295. [4] 中华医学会呼吸病学分会间质性肺疾病学组.特发性肺纤维化诊断和治疗中国专家共识[J].中华结核和呼吸杂志,2016,39(6):427-432. [5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,2(2):67-79,80. [6] Bolaki,Maria,Antoniou,et al.Combined pulmonary fibrosis and emphysema[J].Seminars in Respiratory and Critical Care Medicine,2020,41(2):177-183. [7] 张燕,李岚岚,罗懿,等.N-乙酰半胱氨酸对肺纤维化合并肺气肿综合征患者血清炎症细胞因子的影响[J].第三军医大学学报,2018,40(15):1394-1398. [8] 廖平,孙莉,张艳秋,等.COPD合并肺间质纤维化与血清TGF-β1、IL-6、TNF-α水平的相关性[J].北华大学学报(自然科学版),2021,22(3):353-357. [9] 兰超,戎雪冰,闫宛玉.血清涎液化糖链抗原-6、纤溶酶原激活物抑制物-1及白介素-10在评估肺间质纤维化合并肺癌患者吡非尼酮治疗效果中的价值[J].中国医刊,2023,58(8):833-836. [10] 康冬梅,高勇,马继芳,等.特发性肺间质纤维化并发肺气肿的风险模型构建与评价[J].疑难病杂志,2022,21(12):1236-1241. [11] Kinoshita,Yoshiaki,Watanabe,et al.Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema[J].Histopathology:Official Journal of the British Division of the International Academy of Pathology,2019,74(7):1103-1108. [12] 路浩然,焦瑞,武思羽,等.合并/不合并肺动脉高压的肺纤维化合并肺气肿临床特点分析[J].国际呼吸杂志,2022,42(7):526-531.
2023, Vol. 29 
冀公网安备13080202000677号